← Leaderboards
Kurt R Stenmark
University Of Colorado Denver
$22,132,904
Attributed
$25,588,378
Total exposure
17
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.9M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$85,389,058 · 21
By mechanism
P01$48,427,864 · 11
P50$26,121,644 · 7
T32$6,978,829 · 1
R01$3,860,721 · 2
Top collaborators
- Todd M Bull5 shared
- Peter Buttrick5 shared
- Sonia Castro Flores3 shared
- Tim Lahm2 shared
- Qinghong Zhang1 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Sue Kinnamon$17,923,672
- Colleen Glyde Julian$3,623,041
- David Charles Irwin$10,493,842
- Thomas E Finger$17,925,157
- Karen A Fagan$2,747,862
Others in their field
Top investigators on “Hypoxia”
- James B Edson · Woods Hole Oceanographic Institution$110,367,520
- Albert J Plueddemann · Woods Hole Oceanographic Institution$110,367,520
- David Heimbrook · Leidos Biomedical Research, Inc.$41,862,534
- Nanduri R Prabhakar · Case Western Reserve University$32,967,177
- Zaver M Bhujwalla · Johns Hopkins University$30,055,665
- Donna M. Ferriero · University Of California, San Francisco$27,259,560
Research focus
HypoxiaLungPulmonary HypertensionBlood VesselsAnimalsProgramsCellsInflammatoryVascular RemodelingResearch PersonnelChronicMediatingSignal TransductionInflammationPlayLinkResponseMacrophagePathogenesisPhenotypeMolecularBiologyIn VivoPulmonary Artery Structure
Grant awards (116)
Translational Pulmonary Vascular Biology Program$537,853
T32 · FY2025 · HL · contact PI
Complement Mediated Remodeling in Pulmonary Vascular Disease$2,699,112
P01 · FY2024 · HL · contact PI
Translational Pulmonary Vascular Biology Program$520,122
T32 · FY2024 · HL · contact PI
Immunoglobulin-Driven Activation of the Complement Cascade is a Critical Determinant of PAH Initiation and Progression$460,558
P01 · FY2024 · HL · contact PI
Administrative Core$171,073
P01 · FY2024 · HL · contact PI
Complement Mediated Remodeling in Pulmonary Vascular Disease$2,754,196
P01 · FY2023 · HL · contact PI
Translational Pulmonary Vascular Biology Program$516,767
T32 · FY2023 · HL · contact PI
Immunoglobulin-Driven Activation of the Complement Cascade is a Critical Determinant of PAH Initiation and Progression$469,957
P01 · FY2023 · HL · contact PI
Administrative Core$174,564
P01 · FY2023 · HL · contact PI
Complement Mediated Remodeling in Pulmonary Vascular Disease$2,754,196
P01 · FY2022 · HL · contact PI
Immunoglobulin-Driven Activation of the Complement Cascade is a Critical Determinant of PAH Initiation and Progression$469,957
P01 · FY2022 · HL · contact PI
Chronic Lung Vascular Disease and Vascular Cognitive Impairment$388,748
P01 · FY2022 · HL · contact PI
Translational Pulmonary Vascular Biology Program$248,807
T32 · FY2022 · HL · contact PI
Administrative Core$174,564
P01 · FY2022 · HL · contact PI
Complement Mediated Remodeling in Pulmonary Vascular Disease$2,759,050
P01 · FY2021 · HL · contact PI
Translational Pulmonary Vascular Biology Program$470,744
T32 · FY2021 · HL · contact PI
Immunoglobulin-Driven Activation of the Complement Cascade is a Critical Determinant of PAH Initiation and Progression$469,957
P01 · FY2021 · HL · contact PI
Administrative Core$174,564
P01 · FY2021 · HL · contact PI
Complement Mediated Remodeling in Pulmonary Vascular Disease$2,790,967
P01 · FY2020 · HL · contact PI
Translational Pulmonary Vascular Biology Program$443,010
T32 · FY2020 · HL · contact PI
Administrative Core$398,711
P01 · FY2020 · HL · contact PI
Immunoglobulin-Driven Activation of the Complement Cascade is a Critical Determinant of PAH Initiation and Progression$398,709
P01 · FY2020 · HL · contact PI
Adaptation to Hypoxia$1,979,638
P01 · FY2019 · HL · contact PI
Translational Pulmonary Vascular Biology Program$433,173
T32 · FY2019 · HL · contact PI
Adaptation to Hypoxia$1,979,638
P01 · FY2018 · HL · contact PI
Translational Pulmonary Vascular Biology Program$422,714
T32 · FY2018 · HL · contact PI
Crosstalk Between Metabolism and Inflammation in Pulmonary Hypertension$417,007
P01 · FY2018 · HL · contact PI
Administrative Core$102,140
P01 · FY2018 · HL · contact PI
Adaptation to Hypoxia$1,979,638
P01 · FY2017 · HL · contact PI
Crosstalk Between Metabolism and Inflammation in Pulmonary Hypertension$417,007
P01 · FY2017 · HL · contact PI
Translational Pulmonary Vascular Biology Program$290,422
T32 · FY2017 · HL · contact PI
Administrative Core$102,140
P01 · FY2017 · HL · contact PI
Translational Pulmonary Vascular Biology Program$9,345
T32 · FY2017 · HL · contact PI
Adaptation to Hypoxia$1,983,726
P01 · FY2016 · HL · contact PI
Fibroblasts and Mononuclear Fibrogenic Cells Drive Right Ventricular Pulmonary Ar$687,714
R01 · FY2016 · HL · contact PI
Translational Pulmonary Vascular Biology Program$419,050
T32 · FY2016 · HL · contact PI
Crosstalk Between Metabolism and Inflammation in Pulmonary Hypertension$417,007
P01 · FY2016 · HL · contact PI
Administrative Core$102,140
P01 · FY2016 · HL · contact PI
Adaptation to Hypoxia$1,713,823
P01 · FY2015 · HL · contact PI
Fibroblasts and Mononuclear Fibrogenic Cells Drive Right Ventricular Pulmonary Ar$677,397
R01 · FY2015 · HL · contact PI
Crosstalk Between Metabolism and Inflammation in Pulmonary Hypertension$492,243
R01 · FY2015 · HL · contact PI
Translational Pulmonary Vascular Biology Program$405,948
T32 · FY2015 · HL · contact PI
Crosstalk Between Metabolism and Inflammation in Pulmonary Hypertension$210,241
P01 · FY2015 · HL · contact PI
Administrative Core$102,140
P01 · FY2015 · HL · contact PI
Fibroblasts and Mononuclear Fibrogenic Cells Drive Right Ventricular Pulmonary Ar$671,793
R01 · FY2014 · HL · contact PI
Translational Pulmonary Vascular Biology Program$399,429
T32 · FY2014 · HL · contact PI
Role of the Fibrocyte in Hypoxia Induced Pulmonary Vascular Remodeling and Stiffe$249,025
P01 · FY2014 · HL · contact PI
Adaptations to Hypoxia$249,025
P01 · FY2014 · HL · contact PI
Adaptations to Hypoxia$1,971,570
P01 · FY2013 · HL · contact PI
Fibroblasts and Mononuclear Fibrogenic Cells Drive Right Ventricular Pulmonary Ar$650,494
R01 · FY2013 · HL · contact PI
Translational Pulmonary Vascular Biology Program$390,836
T32 · FY2013 · HL · contact PI
Role of the Fibrocyte in Hypoxia Induced Pulmonary Vascular Remodeling and Stiffe$371,555
P01 · FY2013 · HL · contact PI
Administrative Core$159,717
P01 · FY2013 · HL · contact PI
Adaptations to Hypoxia$2,070,976
P01 · FY2012 · HL · contact PI
Lung Vascular Disease in Infants and Children: Mechanisms and Treatment$1,515,534
P50 · FY2012 · HL · contact PI
Fibroblasts and Mononuclear Fibrogenic Cells Drive Right Ventricular Pulmonary Ar$681,080
R01 · FY2012 · HL · contact PI
Role of the Fibrocyte in Hypoxia Induced Pulmonary Vascular Remodeling and Stiffe$428,856
P01 · FY2012 · HL · contact PI
Administrative Core$184,350
P01 · FY2012 · HL · contact PI
Adaptations to Hypoxia$2,012,580
P01 · FY2011 · HL · contact PI
Lung Vascular Disease in Infants and Children: Mechanisms and Treatment$453,946
P50 · FY2011 · HL · contact PI
Role of the Fibrocyte in Hypoxia Induced Pulmonary Vascular Remodeling and Stiffe$388,501
P01 · FY2011 · HL · contact PI
Administrative Core$167,004
P01 · FY2011 · HL · contact PI
Administrative$64,850
P50 · FY2011 · HL · contact PI
Circulating Fibrocytes in Hyperoxic Lung Vascular Remodeling$64,849
P50 · FY2011 · HL · contact PI
Adaptations to Hypoxia$48,919
P01 · FY2011 · HL · contact PI
Respiration and Circulation During Hypoxia$1
T32 · FY2011 · HL · contact PI
Lung Vascular Disease in Infants and Children: Mechanisms and Treatment$2,201,857
P50 · FY2010 · HL · contact PI
Adaptations to Hypoxia$2,014,773
P01 · FY2010 · HL · contact PI
Respiration and Circulation During Hypoxia$384,137
T32 · FY2010 · HL · contact PI
Role of the Fibrocyte in Hypoxia Induced Pulmonary Vascular Remodeling and Stiffe$379,695
P01 · FY2010 · HL · contact PI
Circulating Fibrocytes in Hyperoxic Lung Vascular Remodeling$355,374
P50 · FY2010 · HL · contact PI
Administrative Core$163,219
P01 · FY2010 · HL · contact PI
Administrative$96,227
P50 · FY2010 · HL · contact PI
Lung Vascular Disease in Infants and Children: Mechanisms and Treatment$2,381,638
P50 · FY2009 · HL · contact PI
Adaptations to Hypoxia$1,938,950
P01 · FY2009 · HL · contact PI
Role of the Fibrocyte in Hypoxia Induced Pulmonary Vascular Remodeling and Stiffe$380,935
P01 · FY2009 · HL · contact PI
Circulating Fibrocytes in Hyperoxic Lung Vascular Remodeling$352,628
P50 · FY2009 · HL · contact PI
Respiration and Circulation During Hypoxia$330,949
T32 · FY2009 · HL · contact PI
Administrative Core$163,751
P01 · FY2009 · HL · contact PI
Administrative$96,343
P50 · FY2009 · HL · contact PI
Lung Vascular Disease in Infants and Children: Mechanisms and Treatment$2,296,239
P50 · FY2008 · HL · contact PI
Respiration and Circulation During Hypoxia$377,761
T32 · FY2008 · HL · contact PI
Circulating Fibrocytes in Hyperoxic Lung Vascular Remodeling$346,619
P50 · FY2008 · HL · contact PI
Administrative$95,508
P50 · FY2008 · HL · contact PI
Lung Vascular Disease in Infants and Children: Mechanisms and Treatment$2,311,542
P50 · FY2007 · HL · contact PI
Adaptations to Hypoxia$2,284,489
P01 · FY2007 · HL · contact PI
Hypoxia induces pulmonary fibroblast differentiation$394,762
P01 · FY2007 · HL · contact PI
Circulating Fibrocytes in Hyperoxic Lung Vascular Remodeling$382,903
P50 · FY2007 · HL · contact PI
Respiration and Circulation During Hypoxia$377,761
T32 · FY2007 · HL · contact PI
Administrative$112,649
P50 · FY2007 · HL · contact PI
Adaptations to Hypoxia$2,294,104
P01 · FY2006 · HL · contact PI
SCOR: Impact of Injury on the Immature Pulmonary Circul*$1,319,019
P50 · FY2006 · HL · contact PI
Project I$437,095
P50 · FY2006 · HL · contact PI
Hypoxia induces pulmonary fibroblast differentiation$232,072
P01 · FY2006 · HL · contact PI
Core B-- Administrative Core$114,214
P50 · FY2006 · HL · contact PI
SCOR: Impact of Injury on the Immature Pulmonary Circul*$1,321,188
P50 · FY2005 · HL
Project I$427,450
P50 · FY2005 · HL
Hypoxia induces pulmonary fibroblast differentiation$227,191
P01 · FY2005 · HL
Core B-- Administrative Core$111,772
P50 · FY2005 · HL
SCOR: Impact of Injury on the Immature Pulmonary Circul*$1,287,575
P50 · FY2004 · HL
Project I$416,503
P50 · FY2004 · HL
Core B-- Administrative Core$108,982
P50 · FY2004 · HL
SCOR: Impact of Injury on the Immature Pulmonary Circul*$1,243,855
P50 · FY2003 · HL
Hypoxia induces pulmonary fibroblast differentiation$215,899
P01 · FY2003 · HL
SCOR: Impact of Injury on the Immature Pulmonary Circul*$1,212,550
P50 · FY2002 · HL
PERLECAN HEPARAN SULFATES--CONTROL OF VSMC REPLICATION AND GENE EXPRESSION$208,827
P50 · FY2002 · HL
SMOOTH MUSCLE CELL HETEROGENEITY IN THE PULMONARY VASCULATURE$208,827
P50 · FY2002 · HL
DISTINCT MECHANISMS OF GROWTH CONTROL IN SELECT SMC SUBPOPULATION$123,636
P01 · FY2002 · HL
SCOR IN PATHOBIOLOGY OF LUNG DEVELOPMENT$1,816,942
P50 · FY2001 · HL
PERLECAN HEPARAN SULFATES--CONTROL OF VSMC REPLICATION AND GENE EXPRESSION$208,827
P50 · FY2001 · HL
SMOOTH MUSCLE CELL HETEROGENEITY IN THE PULMONARY VASCULATURE$208,827
P50 · FY2001 · HL
DISTINCT MECHANISMS OF GROWTH CONTROL IN SELECT SMC SUBPOPULATION$123,636
P01 · FY2001 · HL
SCOR IN PATHOBIOLOGY OF LUNG DEVELOPMENT$1,770,677
P50 · FY2000 · HL
PERLECAN HEPARAN SULFATES--CONTROL OF VSMC REPLICATION AND GENE EXPRESSION$284,904
P50 · FY2000 · HL
SMOOTH MUSCLE CELL HETEROGENEITY IN THE PULMONARY VASCULATURE$284,904
P50 · FY2000 · HL
DISTINCT MECHANISMS OF GROWTH CONTROL IN SELECT SMC SUBPOPULATION$173,506
P01 · FY2000 · HL